Furthermore, we identified a higher percentage of CD44-overexpressed subclonal population (scRNA-seq) in aggressive taxane-resistant DUTXR compared with taxane-sensitive DU145 prostate cancer subtypes. Here, CD44 is linked to prostate carcinoma.